First use of gene therapy to treat growth hormone resistant dwarfism in a mouse model
Open Access
- 1 February 2022
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 29 (6) , 346-356
Abstract
The only treatment tested for growth hormone receptor (GHR) defective Laron Syndrome (LS) is injections of recombinant insulin-like-growth factor 1 (rhIGF1). The response is suboptimal and associated with progressive obesity. In this study, we treated 4–5-week-old Laron dwarf mice (GHR−/−) with an adeno-associated virus expressing murine GHR (AAV-GHR) injection at a dose of 4 × 1010 vector genome per mouse. Serum growth hormone (GH) levels decreased, and GH-responsive IGF1, IGF binding protein 3 (IGFBP3) and acid labile subunit (ALS) increased. There was a significant but limited increase in body weight and length, similar to the response to rhIGF1 treatment in LS patients. All the major organs increased in weight except the brain. Our study is the first to use gene therapy to treat GH-receptor deficiency. We propose that gene therapy with AAV-GHR may eventually be useful for the treatment of human LS.Keywords
This publication has 50 references indexed in Scilit:
- Hepatic Gene Transfer in Neonatal Mice by Adeno-Associated Virus Serotype 8 VectorHuman Gene Therapy, 2012
- Systemic Errors in Quantitative Polymerase Chain Reaction Titration of Self-Complementary Adeno-Associated Viral Vectors and Improved Alternative MethodsHuman Gene Therapy Methods, 2012
- The hormonal action of IGF1 in postnatal mouse growthProceedings of the National Academy of Sciences, 2008
- Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesisProceedings of the National Academy of Sciences, 2007
- Disruption of insulin-like growth factor-I expression in type IIαI collagen-expressing cells reduces bone length and width in micePhysiological Genomics, 2007
- Extrachromosomal Recombinant Adeno-Associated Virus Vector Genomes Are Primarily Responsible for Stable Liver Transduction In VivoJournal of Virology, 2001
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Long-Term Treatment of Growth Hormone Insensitivity Syndrome with IGF-IHormone Research in Paediatrics, 1999
- Three Year IGF-I Treatment of Children with Laron SyndromeJournal of Pediatric Endocrinology and Metabolism, 1995
- Pharmacokinetics of recombinant human insulin‐like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiencyActa Paediatrica, 1993